Demand for Hybrid Protein Blends in Private Label Formulations

Sales of hybrid protein blends in private label formulations across the CIS region, valued at USD 285 million in 2025, are set to reach USD 612 million by 2035, expanding at a CAGR of 7.9%. By protein composition, plant-animal hybrid blends are likely to account for the largest share at 62%, while by distribution, hypermarkets are likely to dominate with a 47% share.